Ciara Louise Freeman

31PUBLICATIONS
165CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targetsNaturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 08, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

|Jun 11, 2026
Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple Myeloma.

|Jan 21, 2026
Meaningful change in patient-reported outcomes after CAR-T for multiple myeloma: differences by race and ethnicity.

Laura B Oswald, Xiaoyin Li, Carina E Ferraris

|Oct 10, 2025
Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Waleed Alduaij, Laurie H Sehn, Jean-Nicolas Champagne

|Sep 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy.

Mark B Meads, Xiaohong Zhao, David Noyes

|Aug 01, 2025
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy.

Binod Dhakal, Othman S Akhtar, David Fandrei

Pageof 6

Frequent Collaborators

10 joint publications

Taiga Nishihori

9 joint publications

Surbhi Sidana

8 joint publications

Diego Villa

8 joint publications

Omar Castaneda Puglianini